As to the biological effect of the mutations, we detected a modest but statistically significant decrease in neutrophils in the MS patients with mutations vs. non-carriers, consistent with reports of neutropenia in STAT3 mutation related T-LGL leukemia and Felty syndrome [24, 25]. Here, STAT3 is linked to T-cell large granular lymphocyte leukemia.